chr16-23467627-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015044.4(GGA2):āc.1805A>Cā(p.Lys602Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,606,566 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015044.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GGA2 | NM_015044.4 | c.1805A>C | p.Lys602Thr | missense_variant | 17/17 | ENST00000309859.8 | |
GGA2 | XM_047433801.1 | c.1775A>C | p.Lys592Thr | missense_variant | 18/18 | ||
GGA2 | XM_047433802.1 | c.1694A>C | p.Lys565Thr | missense_variant | 17/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GGA2 | ENST00000309859.8 | c.1805A>C | p.Lys602Thr | missense_variant | 17/17 | 1 | NM_015044.4 | P1 | |
GGA2 | ENST00000567468.5 | c.625-2229A>C | intron_variant | 2 | |||||
GGA2 | ENST00000568922.1 | n.771A>C | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152184Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000241 AC: 6AN: 248480Hom.: 0 AF XY: 0.00000744 AC XY: 1AN XY: 134436
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1454264Hom.: 0 Cov.: 28 AF XY: 0.00000276 AC XY: 2AN XY: 723922
GnomAD4 genome AF: 0.000105 AC: 16AN: 152302Hom.: 1 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2022 | The c.1805A>C (p.K602T) alteration is located in exon 17 (coding exon 17) of the GGA2 gene. This alteration results from a A to C substitution at nucleotide position 1805, causing the lysine (K) at amino acid position 602 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at